Cholangiolocellular Component Predicts a Biologically Distinct Subgroup of Mass-Forming Intrahepatic Cholangiocarcinoma.

IF 4.3 2区 医学 Q1 Medicine
Cancer Science Pub Date : 2026-05-01 Epub Date: 2026-03-02 DOI:10.1111/cas.70348
Naoto Kubota, Ken Yamazaki, Yasuhito Arai, Minoru Esaki, Nobuyoshi Hiraoka, Hirofumi Shirakawa, Moriaki Tomikawa, Tatsuhiro Shibata, Michiie Sakamoto, Hidenori Ojima
{"title":"Cholangiolocellular Component Predicts a Biologically Distinct Subgroup of Mass-Forming Intrahepatic Cholangiocarcinoma.","authors":"Naoto Kubota, Ken Yamazaki, Yasuhito Arai, Minoru Esaki, Nobuyoshi Hiraoka, Hirofumi Shirakawa, Moriaki Tomikawa, Tatsuhiro Shibata, Michiie Sakamoto, Hidenori Ojima","doi":"10.1111/cas.70348","DOIUrl":null,"url":null,"abstract":"<p><p>Cholangiolocellular carcinoma (CLC) is a histopathological variant of primary liver tumor with unique morphologies, and intrahepatic cholangiocarcinomas (iCCAs) frequently contain a CLC component; however, the biological characteristics of iCCA with CLC remain undescribed. In this study, 36 mass-forming iCCAs (MF-iCCAs), histologically small-duct type iCCA, were classified into CLC(+) iCCAs and CLC(-) iCCAs by the presence/absence of the CLC component. Two genetic subgroups were generated using highly expressed genes in CLC(+) iCCA and CLC(-) iCCA. As the results of clinicopathological and genetic analyses, CLC(+) iCCA had better overall survival and upregulation of stromal- and oxidation-related genes, whereas CLC(-) iCCA showed upregulation of proliferation- and hypoxia-related genes. Two genetic subgroups of iCCA were identified: iCCA-G1, which was related to CLC, and iCCA-G2, which was unrelated to CLC. iCCA-G1 comprised all 14 CLC(+) iCCAs [CLC(+)G1] and 7 of 19 CLC(-) iCCAs [CLC(-)G1], whereas iCCA-G2 was composed only of CLC(-) iCCAs [CLC(-)G2]. CLC(+)G1 and CLC(-)G1 exhibited similar patterns of somatic gene alterations compared with CLC(-)G2. Angiogenesis-related genes were upregulated in CLC(+)G1, and the number of tumor vessels was larger in CLC(+)G1, followed by CLC(-)G1, compared with CLC(-)G2. Further, SPP1 (encoding osteopontin) was identified as a highly expressed angiogenesis-related gene in CLC(+) iCCA. Immunohistochemical expression of osteopontin was high in CLC(+) iCCA, showing apical and/or cytoplasmic expression patterns, which should facilitate the histopathological classification of iCCA-G1 and iCCA-G2. CLC component is useful for predicting a distinct genetic subgroup of MF-iCCA with better prognosis, high angiogenesis, and different gene alteration patterns, indicating different carcinogenic pathways of MF-iCCA.</p>","PeriodicalId":48943,"journal":{"name":"Cancer Science","volume":" ","pages":"1510-1523"},"PeriodicalIF":4.3000,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13134511/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Science","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/cas.70348","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/3/2 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Cholangiolocellular carcinoma (CLC) is a histopathological variant of primary liver tumor with unique morphologies, and intrahepatic cholangiocarcinomas (iCCAs) frequently contain a CLC component; however, the biological characteristics of iCCA with CLC remain undescribed. In this study, 36 mass-forming iCCAs (MF-iCCAs), histologically small-duct type iCCA, were classified into CLC(+) iCCAs and CLC(-) iCCAs by the presence/absence of the CLC component. Two genetic subgroups were generated using highly expressed genes in CLC(+) iCCA and CLC(-) iCCA. As the results of clinicopathological and genetic analyses, CLC(+) iCCA had better overall survival and upregulation of stromal- and oxidation-related genes, whereas CLC(-) iCCA showed upregulation of proliferation- and hypoxia-related genes. Two genetic subgroups of iCCA were identified: iCCA-G1, which was related to CLC, and iCCA-G2, which was unrelated to CLC. iCCA-G1 comprised all 14 CLC(+) iCCAs [CLC(+)G1] and 7 of 19 CLC(-) iCCAs [CLC(-)G1], whereas iCCA-G2 was composed only of CLC(-) iCCAs [CLC(-)G2]. CLC(+)G1 and CLC(-)G1 exhibited similar patterns of somatic gene alterations compared with CLC(-)G2. Angiogenesis-related genes were upregulated in CLC(+)G1, and the number of tumor vessels was larger in CLC(+)G1, followed by CLC(-)G1, compared with CLC(-)G2. Further, SPP1 (encoding osteopontin) was identified as a highly expressed angiogenesis-related gene in CLC(+) iCCA. Immunohistochemical expression of osteopontin was high in CLC(+) iCCA, showing apical and/or cytoplasmic expression patterns, which should facilitate the histopathological classification of iCCA-G1 and iCCA-G2. CLC component is useful for predicting a distinct genetic subgroup of MF-iCCA with better prognosis, high angiogenesis, and different gene alteration patterns, indicating different carcinogenic pathways of MF-iCCA.

胆管细胞成分预测形成团块的肝内胆管癌的生物学独特亚群。
胆管细胞癌(CLC)是原发性肝脏肿瘤的一种组织病理学变异,具有独特的形态,肝内胆管癌(iCCAs)通常含有CLC成分;然而,iCCA合并CLC的生物学特性仍未明确。在本研究中,36例组织学上为小导管型的肿块形成型iCCAs (MF-iCCAs),根据是否存在CLC成分将其分为CLC(+) iCCAs和CLC(-) iCCAs。使用CLC(+) iCCA和CLC(-) iCCA中高表达的基因生成两个遗传亚群。临床病理和遗传学分析结果显示,CLC(+) iCCA总体生存率较高,基质和氧化相关基因表达上调,而CLC(-) iCCA增殖和缺氧相关基因表达上调。我们确定了iCCA的两个遗传亚群:与CLC相关的iCCA- g1和与CLC无关的iCCA- g2。iCCA-G1包括所有14个CLC(+) iCCAs [CLC(+)G1]和19个CLC(-) iCCAs [CLC(-)G1]中的7个,而iCCA-G2仅由CLC(-) iCCAs [CLC(-)G2]组成。与CLC(-)G2相比,CLC(+)G1和CLC(-)G1表现出相似的体细胞基因改变模式。与CLC(-)G2相比,CLC(+)G1中血管生成相关基因表达上调,且CLC(+)G1中肿瘤血管数量较多,CLC(-)G1中肿瘤血管数量次之。此外,SPP1(编码骨桥蛋白)在CLC(+) iCCA中被鉴定为高表达的血管生成相关基因。在CLC(+) iCCA中,骨桥蛋白的免疫组织化学表达较高,表现为顶端和/或细胞质表达模式,这有助于iCCA- g1和iCCA- g2的组织病理学分类。CLC成分可用于预测MF-iCCA的不同遗传亚群,这些亚群预后较好,血管生成高,基因改变模式不同,表明MF-iCCA的不同致癌途径。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cancer Science
Cancer Science ONCOLOGY-
CiteScore
9.90
自引率
3.50%
发文量
406
审稿时长
17 weeks
期刊介绍: Cancer Science (formerly Japanese Journal of Cancer Research) is a monthly publication of the Japanese Cancer Association. First published in 1907, the Journal continues to publish original articles, editorials, and letters to the editor, describing original research in the fields of basic, translational and clinical cancer research. The Journal also accepts reports and case reports. Cancer Science aims to present highly significant and timely findings that have a significant clinical impact on oncologists or that may alter the disease concept of a tumor. The Journal will not publish case reports that describe a rare tumor or condition without new findings to be added to previous reports; combination of different tumors without new suggestive findings for oncological research; remarkable effect of already known treatments without suggestive data to explain the exceptional result. Review articles may also be published.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书